Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "nicotine"

20 News Found

Experts call for easing access to 2mg and 4mg nicotine replacement therapies
Public Health | May 07, 2026

Experts call for easing access to 2mg and 4mg nicotine replacement therapies

With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical


INST scientists develop glowing nanosensor for rapid nicotine, cotinine detection
R&D | April 16, 2026

INST scientists develop glowing nanosensor for rapid nicotine, cotinine detection

he innovation could pave the way for early and low-cost screening of smoking exposure and second-hand smoke biomarkers


Reclassify nicotine replacement therapies as prescription drugs, says Doctor
News | October 07, 2023

Reclassify nicotine replacement therapies as prescription drugs, says Doctor

NRT offers 50% higher success rate in quitting smoking compared to unassisted attempts


World No Tobacco Day: HCG Cancer Hospital Mumbai holds awareness campaigns
Hospitals | June 01, 2026

World No Tobacco Day: HCG Cancer Hospital Mumbai holds awareness campaigns

Initiatives at Churchgate Station and Mahindra & Mahindra focus on early detection, public education, and tobacco-related cancer prevention


Fertin Pharma appoints Aditya Sharma as Managing Director for India operations
People | May 04, 2026

Fertin Pharma appoints Aditya Sharma as Managing Director for India operations

Healthcare and consumer wellness leader brings extensive experience in business transformation, commercial strategy and growth leadership to Fertin India


FDA renews IQOS “reduced-risk” status backing PMI’s smoke-free strategy in regulatory win
News | May 02, 2026

FDA renews IQOS “reduced-risk” status backing PMI’s smoke-free strategy in regulatory win

The renewal covers two versions of the IQOS device and three HEETS tobacco variants


Dr Reddys Laboratories consolidated Q3 FY26 PAT drops to Rs. 1209.8 Cr, expands global pipeline
News | January 23, 2026

Dr Reddys Laboratories consolidated Q3 FY26 PAT drops to Rs. 1209.8 Cr, expands global pipeline

The company has posted net profit of Rs. 4,064.9 crore for the 9 months period ended December 31, 2025


Zydus receives NOC from Health Canada for ZDS-Varenicline Tablets 0.5 &1 mg
Drug Approval | August 07, 2025

Zydus receives NOC from Health Canada for ZDS-Varenicline Tablets 0.5 &1 mg

This is the group’s first NoC approval in Canada


Dr Reddy's Laboratories reports 2% rise in Q1 net profit to Rs. 1,418 Cr
News | July 24, 2025

Dr Reddy's Laboratories reports 2% rise in Q1 net profit to Rs. 1,418 Cr

Revenue increased 11.4 per cent to Rs. 8,545 crore


Paras Health Gurugram raises alarm over surge in tobacco-related cancers
News | May 31, 2025

Paras Health Gurugram raises alarm over surge in tobacco-related cancers

Approximately 35% of male cancer patients and 12% of female cancer patients at Paras Health were diagnosed with tobacco-related cancers